[COVID-19 and arrhythmias]
- PMID: 33081916
- PMCID: PMC7522628
- DOI: 10.1016/j.ancard.2020.09.024
[COVID-19 and arrhythmias]
Abstract
In the pandemic caused by the SARS-CoV2 virus, arrhythmias were not in the foreground. However, the virus seems to affect many organs and the cardiac tropism is now well known. Knowledge in this area is still far from exhaustive, but several series published concerning patients with COVID-19 find a significant proportion of arrhythmias, some of which can potentially lead to a fatal outcome. These rhythm disorders are mainly supraventricular, such as atrial fibrillation (AF) or flutter but also ventricular disorders like ventricular tachycardias (VT) ventricular fibrillation (VF) and more rarely torsades de pointe (TdP). The causes are multiple, due to the multiorgan damage caused by the virus and potential drug interactions. In addition, the question of monitoring rhythm disorders that may emerge in the medium and long term after an infection remains to be explored.
Lors de la pandémie due au virus SARS-CoV2 les troubles du rythme n’ont pas été au premier plan. Cependant, le virus semble atteindre de nombreux organes et le tropisme cardiaque est maintenant bien connu. Les connaissances dans ce domaine sont encore loin d’être exhaustives, mais plusieurs séries publiées concernant les patients atteints de la COVID-19 retrouvent une proportion significative de troubles du rythme, dont certains pouvant potentiellement mener à une issue fatale. Ces troubles du rythmes sont principalement supraventriculaires à type de fibrillation atriale (FA) ou flutter, mais également ventriculaire avec des tachycardies ventriculaires (TV) fibrillation ventriculaire (FV) et plus rarement torsades de pointe (TdP). Les causes en sont multiples, du fait de l’atteinte multiorgane du virus et des interactions médicamenteuses potentielles. Par ailleurs, la question de la surveillance de troubles du rythme pouvant émerger à moyen et long terme après une infection reste à explorer.
Keywords: Arrythmia; Arythmie; COVID-19; Montres ECG; Myocardite; Myocarditis; Smartwatch ECG.
Copyright © 2020. Published by Elsevier Masson SAS.
Figures


Similar articles
-
COVID-19 and Cardiac Arrhythmias.Hamostaseologie. 2021 Oct;41(5):372-378. doi: 10.1055/a-1581-6881. Epub 2021 Oct 25. Hamostaseologie. 2021. PMID: 34695853 Review.
-
A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).J Pharmacol Toxicol Methods. 2013 Sep-Oct;68(2):250-259. doi: 10.1016/j.vascn.2013.01.003. Epub 2013 Jan 19. J Pharmacol Toxicol Methods. 2013. PMID: 23337247
-
Electrocardiographic manifestations of COVID-19.Am J Emerg Med. 2021 Mar;41:96-103. doi: 10.1016/j.ajem.2020.12.060. Epub 2020 Dec 29. Am J Emerg Med. 2021. PMID: 33412365 Free PMC article. Review.
-
Cardiac arrhythmias: diagnosis and management. The tachycardias.Crit Care Resusc. 2002 Mar;4(1):35-53. Crit Care Resusc. 2002. PMID: 16573402
-
[The problem of ventricular flutter and fibrillation].Z Gesamte Inn Med. 1981 Mar 15;36(6):277-80 suppl. Z Gesamte Inn Med. 1981. PMID: 7257463 German.
References
-
- Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.3557. [Article sous presse. Consulté le 26 août 2020. Disponible sur : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385689/] - DOI - PMC - PubMed
-
- Estabragh Z.R., Mamas M.A. The cardiovascular manifestations of influenza: a systematic review. Int J Cardiol. 2013;167(6):2397–2403. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous